Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization

Neuroscience Letters

Volumn 534, Issue 1, 2013, Pages 12-17

  Küntzelmann, Anika ^a   Guenther, Thomas ^a   Haberkorn, Uwe ^b   Essig, Marco ^c   Giesel, Frederik ^c   Henze, Romy ^c   Schroeter, Matthias L ^a,d,e   Schröder, Johannes ^b   Schönknecht, Peter ^a,b,e  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^e LIFE Leipzig Research Center for Civilization Diseases   (Germany)

Author keywords

Alzheimer's disease dementia; FDG PET; Intensity normalization; Prodromal Alzheimer's disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ANGULAR GYRUS; ANTERIOR CINGULATE; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; BRAIN STEM; CEREBELLUM; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; MINI MENTAL STATE EXAMINATION; ORBITAL CORTEX; PONS; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PREMOTOR CORTEX; PRIORITY JOURNAL; PRODROMAL ALZHEIMER DISEASE; SOMATOSENSORY CORTEX; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; CEREBELLUM; COGNITION DISORDERS; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GLUCOSE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; PRODROMAL SYMPTOMS; RADIOPHARMACEUTICALS; TEMPORAL LOBE;

EID: 84873059968     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.11.026     Document Type: Article

References (25)

1. Alavi A., Dann R., Chawluk J., Alavi J., Kushner M., Reivich M. Positron emission tomography imaging of regional cerebral glucose metabolism. Seminars in Nuclear Medicine 1986, 16:2-34.
2. Borghammer P., Chakravarty M., Jonsdottir K.Y., Sato N., Matsuda H., Ito K., Arahata Y., Kato T., Gjedde A. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Structure and Function 2010, 214:303-317.
3. Cavedo E., Frisoni G.B. The dynamic marker hypothesis of Alzheimer's disease and its implications for clinical imaging. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2011, 55:237-249.
4. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurology 2007, 6:734-746.
5. Dubois B., Feldman H.H., Jacova C., Cummings J.L., Dekosky S.T., Barberger-Gateau P., Delacourte A., Frisoni G., Fox N.C., Galasko D., Gauthier S., Hampel H., Jicha G.A., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Sarazin M., de Souza L.C., Stern Y., Visser P.J., Scheltens P. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology 2010, 9:1118-1127.
6. Dukart J., Mueller K., Horstmann A., Vogt B., Frisch S., Barthel H., Becker G., Möller H.E., Villringer A., Sabri O., Schroeter M.L. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 2010, 49:1490-1495.
7. Friston K.J., Ashburner J., Poline J.B., Frith C.D., Heather J.D., Frackowiak R.S.J. Spatial registration and normalization of images. Human Brain Mapping 1995, 2:165-189.
8. Fujimoto T., Matsumoto T., Fujita S., Takeuchi K., Nakamura K., Mitsuyama Y., Kato N. Changes in glucose metabolism due to aging and gender-related differences in the healthy human brain. Psychiatry Research 2008, 164:58-72.
9. Guenther T., Schönknecht P., Becker G., Olbrich S., Sander C., Hesse S., Meyer P.M., Luthardt J., Hegerl U., Sabri O. Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment. Neuroimage 2011, 56:93-101.
10. Herholz K. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Review of Neurotherapeutics 2010, 10:1667-1673.
11. Landau S.M., Harvey D., Madison C.M., Koeppe R.A., Reimand E.M., Foster N.L., Weiner M.W., Jagust W.J. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging 2011, 32:1207-1218.
12. Loeb C., Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983, 14:399-401.
13. S. Morbelli, A. Drzezga, R. Perneczky, G.B. Frisoni, A. Caroli, B.N. van Berckel, R. Ossenkoppele, E. Guedj, M. Didic, A. Brugnolo, G. Sambuceti, M. Pagani, E. Salmon, F. Nobili, Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging (2012) [Epub ahead of print].
14. Olbrich S., Jödicke J., Sander C., Himmerich H., Hegerl U. ICA-based muscle artefact correction of EEG data: what is muscle and what is brain? Comment on McMenamin et al. Neuroimage 2010, 54:1-3. discussion 4-9.
15. Pagani M., Dessi B., Morbelli S., Brugnolo A., Salmaso D., Piccini A., Mazzei D., Villavecchia G., Larsson S.A., Rodriguez G., Nobili F. MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Current Alzheimer Research 2010, 7:287-294.
16. Salmon E., Collette F., Degueldre C., Lemaire C., Franck G. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Human Brain Mapping 2000, 10:39-48.
17. Samuraki M., Matsunari I., Chen W.-P., Yajima K., Yanase D., Fujikawa A., Takeda N., Nishimura S., Matsuda H., Yamada M. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 2007, 34:1658-1669.
18. Santens P., De Bleecker J., Goethals P., Strijckmans K., Lemahieu I., Slegers G., Dierckx R., De Reuck J. Differential regional cerebral uptake of 18F-fluoro-2-deoxy-d-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis. European Neurology 2001, 45:19-27.
19. Schönknecht O.D., Hunt A., Toro P., Guenther T., Henze M., Haberkorn U., Schröder J., Bihemispheric cerebral F.D.G. PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease. Clinical EEG and Neuroscience 2011, 42:71-76.
20. Schröder J., Buchsbaum M.S., Shihabuddin L., Tang C., Wei T.C., Spiegel-Cohen J., Hazlett E.A., Abel L., Luu-Hsia C., Ciaravolo T.M., Marin D., Davis K.L. Patterns of cortical activity and memory performance in Alzheimer's disease. Biological Psychiatry 2001, 49:426-436.
21. Schroeter M.L., Stein T., Maslowski N., Neumann J. Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 2009, 47:1196-1206.
22. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain 1988, Thieme, Paris.
23. Yakushev I., Landvogt C., Buchholz H.G., Fellgiebel A., Hammers A., Scheurich A., Schmidtmann I., Gerhard A., Schreckenberger M., Bartenstein P. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Research 2008, 30:143-153.
24. Yakushev I., Hammers A., Fellgiebel A., Schmidtmann I., Scheurich A., Buchholz H.G., Peters J., Bartenstein P., Lieb K., Schreckenberger M. SPM-based count normalization provides excellent discrimination of mild Alzheimer' disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 2009, 44:43-50.
25. Yokokura M., Mori N., Yagi S., Yoshikawa E., Kikuchi M., Yoshihara Y., Wakuda T., Sugihara G., Takebayashi K., Suda S., Iwata Y., Ueki T., Tsuchiya K.J., Suzuki K., Nakamura K., Ouchi Y. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 2011, 38:343-351.